Timely new launches in US market, India outperformance key for margin gains

Pharma major Cipla's active pharmaceutical ingredients business led on the sales front with a growth of 42 per cent, while the domestic sales were up 7 per cent year-on-year

May 13, 2024 - 19:30
 0  6
Timely new launches in US market, India outperformance key for margin gains
Pharma major Cipla's active pharmaceutical ingredients business led on the sales front with a growth of 42 per cent, while the domestic sales were up 7 per cent year-on-year

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow